The expression, regulation and function of secreted protein, acidic, cysteine-rich in the follicle-luteal transition

Reproduction

Volumn 144, Issue 3, 2012, Pages 361-372

  Joseph, Chitra ^a   Hunter, Morag G ^a   Sinclair, Kevin D ^a   Robinson, Robert S ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; FIBRONECTIN; LUTEINIZING HORMONE; LYSYLGLYCYLHISTIDYLLYSINE; OSTEONECTIN; PEPTIDE FRAGMENT; PROGESTERONE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS HEMORRHAGICUM; CORPUS LUTEUM; COW; ENDOTHELIUM CELL; FEMALE; GRANULOSA CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; OVARY FOLLICLE; OVARY FOLLICLE CELL; PRIORITY JOURNAL; PROGESTERONE SYNTHESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; THECA CELL; UPREGULATION; WESTERN BLOTTING;

ANIMALS; CATTLE; CELLS, CULTURED; CORPUS LUTEUM; ENDOTHELIAL CELLS; FEMALE; FIBROBLAST GROWTH FACTOR 2; FIBRONECTINS; GENE EXPRESSION; GRANULOSA CELLS; LUTEAL CELLS; LUTEINIZATION; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEONECTIN; OVARIAN FOLLICLE; PROGESTERONE; THECA CELLS; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84865170925     PISSN: 14701626     EISSN: 17417899     Source Type: Journal    
DOI: 10.1530/REP-12-0099     Document Type: Article

References (54)

1. Amselgruber WM, Schafer M & Sinowatz F 1999 Angiogenesis in the bovine corpus luteum: an immunocytochemical and ultrastructural study. Anatomia, Histologia, Embryologia 28 157-166. (doi:10.1046/j.1439-0264.1999.00195.x)
2. Bagavandoss P, Sage EH & Vernon RB 1998 Secreted protein, acidic and rich in cysteine (SPARC) and thrombospondin in the developing follicle and corpus luteum of the rat. Journal of Histochemistry and Cytochemistry 46 1043-1049. (doi:10.1177/002215549804600908)
3. Berisha B, Steffl M, Amselgruber W & Schams D 2006 Changes in fibroblast growth factor 2 and its receptors in bovine follicles before and after GnRH application and after ovulation. Reproduction 131 319-329. (doi:10.1530/rep.1.00798)
4. Chlenski A, Guerrero LJ, Salwen HR, Yang Q, Tian Y, Morales La Madrid A, Mirzoeva S, Bouyer PG, Xu D, Walker M et al. 2011 Secreted protein acidic and rich in cysteine is a matrix scavenger chaperone. PLoS ONE 6 e23880. (doi:10.1371/journal.pone.0023880)
5. Curry TE & Smith MF 2006 Impact of extracellular matrix remodeling on ovulation and the folliculo-luteal transition. Seminars in Reproductive Medicine 24 228-241. (doi:10.1055/s-2006-948552)
6. DaCosta Byfield S, Major C, Laping NJ & Roberts AB 2004 SB-505124 is a selective inhibitor of transforming growth factor-β type I receptors ALK4, ALK5, and ALK7. Molecular Pharmacology 65 744-752. (doi:10.1124/mol.65.3. 744)
7. Dow MPD, Bakke LJ, Cassar CA, Peters MW, Pursley JR & Smith GW 2002 Gonadotropin surge-induced up-regulation of the plasminogen activators (tissue plasminogen activator and urokinase plasminogen activator) and the urokinase plasminogen activator receptor within bovine periovulatory follicular and luteal tissue. Biology of Reproduction 66 1413-1421. (doi:10.1095/biolreprod66.5.1413)
8. van den Driesche S, Myers M, Gay E, Thong KJ & Duncan WC 2008 HCG up-regulates hypoxia inducible factor-1α in luteinized granulosa cells: implications for the hormonal regulation of vascular endothelial growth factor A in the human corpus luteum. Molecular Human Reproduction 14 455-464. (doi:10.1093/molehr/gan040)
9. Espey LL & Richards JS 2002 Temporal and spatial patterns of ovarian gene transcription following an ovulatory dose of gonadotropin in the rat. Biology of Reproduction 67 1662-1670. (doi:10.1095/biolreprod.102.005173)
10. Fazzini M, Vallejo G, Colman-Lerner A, Trigo R, Campo S, Barañao JL & Saragüeta PE 2006 Transforming growth factor β1 regulates follistatin mRNA expression during in vitro bovine granulosa cell differentiation. Journal of Cellular Physiology 207 40-48. (doi:10.1002/jcp. 20533)
11. Finney DJ 1988 Was this in your statistics textbook 3. Design and analysis. Experimental Agriculture 24 421-432.
12. Flaumenhaft R, Abe M, Mignatti P & Rifkin DB 1992 Basic fibroblast growth factor-induced activation of latent transforming growth factor β in endothelial cells: regulation of plasminogen activator activity. Journal of Cell Biology 118 901-909. (doi:10.1083/jcb.118.4.901)
13. Fujita T, Shiba H, Sakata M, Uchida Y, Ogawa T & Kurihara H 2002 Effects of transforming growth factor-β 1 and fibronectin on SPARC expression in cultures of human periodontal ligament cells. Cell Biology International 26 1065-1072. (doi:10.1006/cbir.2002.0966)
14. Funk SE & Sage EH 1993 Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts. Journal of Cellular Physiology 154 53-63. (doi:10.1002/jcp.1041540108)
15. Gangrade BK, Gotcher ED, Davis JS & May JV 1993 The secretion of transforming growth factor-β by bovine luteal cells in vitro. Molecular and Cellular Endocrinology 93 117-123. (doi:10.1016/0303-7207(93)90114-Y)
16. Goldblum SE, Ding X, Funk SE & Sage EH 1994 SPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barrier function. PNAS 91 3448-3452. (doi:10.1073/pnas.91.8.3448)
17. Hasselaar P & Sage EH 1992 SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells. Journal of Cellular Biochemistry 49 272-283. (doi:10.1002/jcb.240490310)
18. Hazzard TM, Xu FH & Stouffer RL 2002 Injection of soluble vascular endothelial growth factor receptor 1 into the preovulatory follicle disrupts ovulation and subsequent luteal function in rhesus monkeys. Biology of Reproduction 67 1305-1312. (doi:10.1095/biolreprod67.4.1305)
19. Heldin CH, Miyazono K & ten Dijke P 1997 TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390 465-471. (doi:10.1038/37284)
20. Iruela-Arispe ML, Lane TF, Redmond D, Reilly M, Bolender RP, Kavanagh TJ & Sage EH 1995 Expression of SPARC during development of the chicken chorioallantoic membrane: evidence for regulated proteolysis in vivo. Molecular Biology of the Cell 6 327-343.
21. Irving-Rodgers HF, Catanzariti KD, Aspden WJ, D'Occhio MJ & Rodgers RJ 2006 Remodeling of extracellular matrix at ovulation of the bovine ovarian follicle. Molecular Reproduction and Development 73 1292-1302. (doi:10.1002/mrd.20580)
22. Kato Y, Lewalle JM, Baba Y, Tsukuda M, Sakai N, Baba M, Kobayashi K, Koshika S, Nagashima Y, Frankenne F et al. 2001 Induction of SPARC by VEGF in human vascular endothelial cells. Biochemical and Biophysical Research Communications 287 422-426. (doi:10.1006/bbrc.2001.5622)
23. Knight PG & Glister C 2006 TGF-β superfamily members and ovarian follicle development. Reproduction 132 191-206. (doi:10.1530/rep.1.01074)
24. Koos RD 1995 Increased expression of vascular endothelial growth/permeability factor in the rat ovary following an ovulatory gonadotropin stimulus: potential roles in follicle rupture. Biology of Reproduction 52 1426-1435. (doi:10.1095/biolreprod52.6.1426)
25. Lane TF, Iruela-Arispe ML, Johnson RS & Sage EH 1994 SPARC is a source of copper-binding peptides that stimulate angiogenesis. Journal of Cell Biology 125 929-943. (doi:10.1083/jcb.125.4.929)
26. Lowry SR 1992 Use and misuse of multiple comparisons in animal-experiments. Journal of Animal Science 70 1971-1977.
27. Magee RM, Hagan S, Hiscott PS, Sheridan CM, Carron JA, McGalliard J & Grierson I 2000 Synthesis of osteonectin by human retinal pigment epithelial cells is modulated by cell density. Investigative Ophthalmology & Visual Science 41 2707-2711. (Pubitemid 30624403)
28. Mamluk R, Wolfenson D & Meidan R 1998 LH receptor mRNA and cytochrome P450 side-chain cleavage expression in bovine theca and granulosa cells luteinized by LH or forskolin. Domestic Animal Endocrinology 15 103-114. (doi:10.1016/S0739-7240(97)00085-4)
29. Mann GE & Lamming GE 2001 Relationship between maternal endocrine environment, early embryo development and inhibition of the luteolytic mechanism in cows. Reproduction 121 175-180. (doi:10.1530/rep.0.1210175)
30. McRae RS, Johnston HM, Mihm M & O'Shaughnessy PJ 2005 Changes in mouse granulosa cell gene expression during early luteinization. Endocrinology 146 309-317. (doi:10.1210/en.2004-0999)
31. Motamed K, Blake DJ, Angello JC, Allen BL, Rapraeger AC, Hauschka SD & Sage EH 2003 Fibroblast growth factor receptor-1 mediates the inhibition of endothelial cell proliferation and the promotion of skeletal myoblast differentiation by SPARC: a role for protein kinase A. Journal of Cellular Biochemistry 90 408-423. (doi:10.1002/jcb.10645)
32. Okuda K, Uenoyama Y, Naito C, Sakabe Y & Kawate N 1999 Luteinizing hormone receptors in the bovine corpus luteum during the oestrous cycle and pregnancy. Reproduction, Fertility, and Development 11 147-151. (doi:10.1071/RD99027)
33. Pepper MS 1997 Transforming growth factor-β: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine & Growth Factor Reviews 8 21-43. (doi:10.1016/S1359-6101(96)00048-2)
34. Phan E, Ahluwalia A & Tarnawski AS 2007 Role of SPARC - matricellular protein in pathophysiology and tissue injury healing. Implications for gastritis and gastric ulcers. Medical Science Monitor 13 RA25-RA30. (Pubitemid 46238669)
35. Rempel SA, Golembieski WA, Fisher JL, Maile M & Nakeff A 2001 SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins. Journal of Neuro-Oncology 53 149-160. (doi:10.1023/A:1012201300188)
36. Richards JS 2001 Perspective: the ovarian follicle - a perspective in 2001. Endocrinology 142 2184-2193. (doi:10.1210/en.142.6.2184)
37. Richards J, Russell D, Robker R, Dajee M & Alliston T 1998 Molecular mechanisms of ovulation and luteinization. Molecular and Cellular Endocrinology 145 47-54. (doi:10.1016/S0303-7207(98)00168-3)
38. Robinson RS, Nicklin LT, Hammond AJ, Schams D, Hunter MG & Mann GE 2007 Fibroblast growth factor 2 is more dynamic than vascular endothelial growth factor a during the follicle-luteal transition in the cow. Biology of Reproduction 77 28-36. (doi:10.1095/biolreprod.106.055434)
39. Robinson RS, Hammond AJ, Mann GE & Hunter MG 2008a A novel physiological culture system that mimics luteal angiogenesis. Reproduction 135 405-413. (doi:10.1530/REP-07-0370)
40. Robinson RS, Hammond AJ, Wathes DC, Hunter MG & Mann GE 2008b Corpus luteum-endometrium-embryo interactions in the dairy cow: underlying mechanisms and clinical relevance. Reproduction in Domestic Animals 43 104-112. (doi:10.1111/j.1439-0531.2008.01149.x)
41. Robinson RS, Woad KJ, Hammond AJ, Laird M, Hunter MG & Mann GE 2009 Angiogenesis and vascular function in the ovary. Reproduction 138 869-881. (doi:10.1530/REP-09-0283)
42. 2+-dependent binding to the extracellular matrix. Journal of Cell Biology 109 341-356. (doi:10.1083/jcb.109.1.341)
43. Seto-Young D, Avtanski D, Varadinova M, Park A, Suwandhi P, Leiser A, Parikh G & Poretsky L 2011 Differential roles of MAPK-Erk1/2 and MAPK-p38 in insulin or insulin-like growth factor-I (IGF-I) signaling pathways for progesterone production in human ovarian cells. Hormone and Metabolic Research 43 386-390. (doi:10.1055/s-0031-1273760)
44. Shiba H, Fujita T, Doi N, Nakamura S, Nakanishi K, Takemoto T, Hino T, Noshiro M, Kawamoto T, Kurihara H et al. 1998 Differential effects of various growth factors and cytokines on the syntheses of DNA, type I collagen, laminin, fibronectin, osteonectin/secreted protein, acidic and rich in cysteine (SPARC), and alkaline phosphatase by human pulp cells in culture. Journal of Cellular Physiology 174 194-205. (doi:10.1002/(SICI)1097-4652(199802)174:2〈194::AID- JCP7〉3.0.CO;2-J)
45. Silvester LM & Luck MR 1999 Distribution of extracellular matrix components in the developing ruminant corpus luteum: a wound repair hypothesis for luteinization. Journal of Reproduction and Fertility 116 187-198. (doi:10.1530/jrf.0.1160187)
46. Sriperumbudur R, Zorrilla L & Gadsby JE 2010 Transforming growth factor-β (TGFβ) and its signaling components in peri-ovulatory pig follicles. Animal Reproduction Science 120 84-94. (doi:10.1016/j.anireprosci. 2010.03.003)
47. Tennant JR 1964 Evaluation of the tryphan blue technique for determination of cell viability. Transplantation 2 685-694. (doi:10.1097/ 00007890-196411000-00001)
48. Vogt J, Traynor R & Sapkota GP 2011 The specificities of small molecule inhibitors of the TGFβ and BMP pathways. Cellular Signalling 23 1831-1842. (doi:10.1016/j.cellsig.2011.06.019)
49. Weaver MS, Workman G & Sage EH 2008 The copper binding domain of SPARC mediates cell survival in vitro via interaction with integrin β1 and activation of integrin-linked kinase. Journal of Biological Chemistry 283 22826-22837. (doi:10.1074/jbc.M706563200)
50. Woad KJ, Hammond AJ, Hunter M, Mann GE, Hunter MG & Robinson RS 2009 FGF2 is crucial for the development of bovine luteal endothelial networks in vitro. Reproduction 138 581-588. (doi:10.1530/REP-09-0030)
51. Wrana JL, Overall CM & Sodek J 1991 Regulation of the expression of a secreted acidic protein rich in cysteine (SPARC) in human fibroblasts by transforming growth factor β, Comparison of transcriptional and posttranscriptional control with fibronectin and type I collagen. European Journal of Biochemistry 197 519-528. (doi:10.1111/j.1432-1033.1991.tb15940.x)
52. Wulff C, Wilson H, Rudge JS, Wiegand SJ, Lunn SF & Fraser HM 2001 Luteal angiogenesis: prevention and intervention by treatment with vascular endothelial growth factor Trap(A40). Journal of Clinical Endocrinology and Metabolism 86 3377-3386. (doi:10.1210/jc.86.7.3377)
53. Yan Q & Sage EH 1999 SPARC, a matricellular glycoprotein with important biological functions. Journal of Histochemistry and Cytochemistry 47 1495-1506. (doi:10.1177/002215549904701201)
54. Zheng X, Boerboom D & Carrière PD 2009 Transforming growth factor-β1 inhibits luteinization and promotes apoptosis in bovine granulosa cells. Reproduction 137 969-977. (doi:10.1530/REP-08-0365)